Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study

Authors: Reinhard Dummer, Paola Queirolo, Pauline Duhard, Youyou Hu, Dao Wen Wang, Sérgio Jobim Azevedo, Caroline Robert, Paolo A. Ascierto, Vanna Chiarion‐Sileni, P. Pronzato, Francesco Spagnolo, Karmele Mujika Eizmendi, Gabriella Liszkay, Luis de la Cruz‐Merino, Hussein A. Tawbi - The Lancet 2023 cited by 57